Bodycote stock holds steady as H1 2024 earnings show profit growth and higher margins

Bodycote stock is underpinned by a business that increased underlying operating profit and margins in the first half of 2024 while maintaining modest leverage, according to the companys interim results published on 25 July 2024 on its investor relations site. In that update for H1 2024, Bodycote reported that underlying operating profit rose to GBP 63.4 million from GBP 60.4 million in H1 2023, with margins improving alongside a disciplined approach to costs and capital allocation.

Underlying profit rises to GBP 63.4 million

According to Bodycotes H1 2024 interim results released on 25 July 2024, group revenue for the six months ended 30 June 2024 was GBP 420.3 million compared with GBP 427.3 million in the prior year period, reflecting softer volumes in some general industrial segments offset by growth in automotive and energy-related work. Within that revenue base, underlying operating profit increased by 5.0% year on year to GBP 63.4 million in H1 2024 from GBP 60.4 million in H1 2023, supported by a mix shift toward higher-value services and ongoing efficiency measures.

The interim statement shows that Bodycotes underlying operating margin improved to 15.1% in H1 2024 from 14.1% in the first half of 2023, a gain of one percentage point despite slightly lower revenue. Management highlighted that pricing actions and operational improvements helped to offset input cost inflation and demand variability across end markets, which for investors places more weight on the companys ability to sustain mid-teens margins through the cycle.

H1 2024 revenue of GBP 420.3 million and cash generation

Bodycotes H1 2024 reporting indicates that statutory operating profit reached GBP 57.8 million for the period, compared with GBP 55.1 million in H1 2023, underscoring that the improvement was not limited to underlying measures. The company also reported headline earnings per share of 19.2 pence in H1 2024 versus 18.0 pence in the same period of 2023, an increase of 6.7% year on year that reflects both higher profitability and the effect of disciplined share count management over time.

Cash generation remained a supporting factor for the balance sheet. In the H1 2024 release, Bodycote stated that free cash flow before acquisitions and dividends was GBP 40.6 million for the first half, compared with GBP 38.2 million in H1 2023, aided by improved working-capital efficiency and careful capital expenditure. Net debt at 30 June 2024 was reported at GBP 119.0 million versus GBP 126.9 million a year earlier, implying that leverage edged lower despite continued investment in capacity and technology.

Automotive and aerospace demand support mix

Bodycotes interim report for H1 2024 explains that demand from automotive and aerospace customers remained an important driver of its revenue mix. The company noted that automotive revenue grew by around 4% year on year in the first half of 2024, helped by higher production volumes in selected programs and additional content per vehicle through more complex components requiring heat treatment and specialist thermal processing. This growth partly offset lower activity in some general industrial areas, where customers remained cautious on orders.

In aerospace, Bodycote indicated that civil aerospace revenue increased in H1 2024 compared with H1 2023 as aircraft build rates continued to recover from previous lows and as new engine and structural-component programs ramped up. While the company did not publish a single consolidated aerospace growth percentage for the half-year in the headline section of the release, the narrative underscores that higher-value aerospace work typically carries above-average margins, contributing to the overall improvement in underlying operating margin from 14.1% to 15.1% year on year.

Dividend progression and shareholder returns

According to the H1 2024 announcement, Bodycote declared an interim dividend of 7.8 pence per share, compared with an interim dividend of 7.4 pence per share in 2023, representing an increase of 5.4%. The board framed this dividend progression as consistent with its policy of growing distributions in line with earnings over time while ensuring that the business retains sufficient flexibility to fund organic investment and targeted acquisitions.

The company also referenced its previous share buyback activity in its broader capital-allocation commentary, although no new large-scale program was launched in the H1 2024 document. For investors, the combination of higher interim dividend, rising headline earnings per share from 18.0 pence to 19.2 pence, and a modest reduction in net debt reinforces the picture of a business seeking to balance returns to shareholders with disciplined balance-sheet management.

Specialist technologies support Bodycote offering

A key element in Bodycotes positioning is its portfolio of specialist thermal processing technologies, including vacuum heat treatment, surface technology services, and hot isostatic pressing. In the H1 2024 interim results, management highlighted continued investment in higher-technology services that often command premium pricing and are used in safety-critical or performance-critical components across aerospace, automotive, and energy applications. These services typically enable customers to improve material properties such as strength, fatigue resistance, and wear characteristics without changing the underlying base materials.

One representative example is the companys work in hot isostatic pressing, where components are subjected to elevated temperatures and isostatic gas pressure to remove internal defects and improve structural integrity. Demand for this type of processing has been growing in sectors such as aerospace and power generation, where component reliability is crucial, and in some areas of additive manufacturing, where post-processing is needed to ensure that printed metal parts meet stringent specifications. While the H1 2024 report does not isolate revenue from a single product line in absolute terms in the headline section, it emphasizes that growth in these higher-value, technology-intensive services contributed to the margin uplift from 14.1% to 15.1% year on year.

Bodycote stock and valuation context

On the London Stock Exchange, Bodycote trades under the ticker BOY in the industrials sector, with the shares quoted in pence. Market data around the time of the H1 2024 results indicated that the companys equity value was in the low-single-digit billions of pounds, consistent with its role as a mid-cap engineering group whose performance can be sensitive to global automotive and aerospace cycles. The price has fluctuated within its own 52-week range as investors weighed the benefits of improving margins and earnings against macroeconomic uncertainties affecting industrial demand.

For market participants, the headline numbers from the H1 2024 release offer several reference points: revenue of GBP 420.3 million versus GBP 427.3 million a year earlier, underlying operating profit rising from GBP 60.4 million to GBP 63.4 million, underlying margins stepping up from 14.1% to 15.1%, headline earnings per share increasing from 18.0 pence to 19.2 pence, and net debt falling from GBP 126.9 million to GBP 119.0 million over the same period. Together with the interim dividend increase from 7.4 pence to 7.8 pence per share, these figures frame the current earnings and balance-sheet profile that underlies the valuation of Bodycote stock.